Medtronic and DaVita’s dialysis venture appears to be called Mozarc Medical

13 Mar 2023
www.massdevice.com
The companies used “NewCo” as a placeholder when announcing the new company last year and said a renaming and rebranding would come when the deal closes sometime in 2023. Since then, Medtronic has filed trademark applications with the U.S. Patent and Trademark Office for Mozarc and Mozarc Medical relating to dialysis products. Medtronic listed itself as the applicant on five applications filed in August and December. Four more recent applications, filed in January, list Mozarc Medical US LLC as the applicant. All list the same attorney of record and the address of Medtronic’s Fridley, Minnesota headquarters. Meanwhile, law firm DLA Piper — which represents Medtronic — filed last year to incorporate Mozarc Medical Ireland in Dublin, where Medtronic is officially headquartered. The U.S. trademark filings describe the Mozarc logo as “the word ‘Mozarc’ with the ‘o’ split into top and bottom; the entire word [is] blue except for the bottom half of the ‘o’, which is green.” It’s not clear when Mozarc Medical will launch, but Medtronic’s recent voluntary early retirement package (VERP) offer specifically excluded employees who “are conveying with Mozarc Medical.” Eligible employees had until last week to accept that deal, which required retirement on or before April 28. A job posting for a benefits director who would “ensure global benefits offering for Mozarc are ready for Day 1” said the position would end March 31. Searching U.S. Securities and Exchange Commission filings for the word Mozarc turns up only one document, a September 2022 employment contract for Avita Medical CEO James Corbett that identifies him as a “board member of privately-held Mozarc.” Corbett declined to comment when reached by MassDevice. A Medtronic spokesperson did not offer any information about Mozarc when asked about it by MassDevice last week. The Mozarc trademark applications cover a long list of goods and services: Boston-area job postings that are no longer live but cached online say:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.